UNGEN DAVIES CA14CER FUND CIO
Charity reglstration number 11fj0922
ANIIUAL REPORT AMD FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022

UNGEN DAVIES CANCER FUND CIO
LEGAL AND ADMINISTRATIVE INFORMATION
Mr5 AJ Thom MBE DL IChairrr*n)
MrA Kli ley (WKe Gh8iTmanl
Mrs C H Thom￿ ITre8suwI
Dr N N Srihari
Dr G Eatough
Mr D Jacksc
MrsA Kenny
Mrs F K Huich&son
MrT c￿￿r
Mrc LÈ8ke
Mrs J L Bsaver
Mrs V A Edwards
Dr J R j¢)hrtsC￿ MBE
Charity number
1161)W22
Principal address
Fundrdising Office
rJo Hamar Centre
Royal Shrewsbjry Hospital North
Shrevlsbury
Shropshire
SY3 8XQ
Auditor
Emstrey Fb)use
Shrewsbury Business Park
shr￿S￿ry
SY2 fjLG
aankers
Santander PLC
Bridle Road
B¢xbde
Merseysm
L30 4GB
Uoyds Bank PLC
2138 Coventy Road
Sheldon
8imiirKJham
B26 IJW
Viryin Money PLC
Jubilee Housè
NewGasUe upon TYT
NE3 4PL

LINGEN DAVIES CANCER FUND CIO
TRUSTEES. REPORT
FOR THE YEAR ENDED 31 MARCH 2022
The Trustee5 present thwr arwj acc￿nts for the year erthl 31 Marth 2022.
The fin8n¢ial statements have been prep￿e￿ in accordance ¥*ilh the aLU)ullting set out in note 1 to the
financial statements arKI WTnFAy wrth the tharitys goveming do(xJtll8nL the Charibes Act 2011 Ènd 'Accounting and
RepcTrrbng by Charities.. Statement of Recommended Practice applI(%1￿e to charitses preparing thalr accounts in
accordance wth the Financial Rewting Standard applicaNe in Ihe UK aFKI Republic of Ireland IFRS 102)" las
rnended accounting peric¥Js (winwong 1 JanLOry 20191.
Obje¢tbves and actF¥ities
Lingen Davies exists to enhance ￿ncer serwces and improve lives. here in our cxjmnwnty.
In line vthh ryJT consbtUti￿. the object of Ihe tharity i8:
(al The relief. ￿Olty or mainty of ￿nCer patienls resKlirvJ in Shrtjpshire. Telford and Wreknn and Mid Wales {the
charity's area) in pathul8r t*rt not exdusivdy by provmling:
lil Gtsnts to support the work of IWK%I hea11hca￿ professionats. based wilh5n and serving can(x patients
in the charitys area and
lill SeNces dir8d to (*ncer patients rf the Twstees deem appropriate
Ib} The prevention of canw by r8isM)g aWarer￿ in the charyiys arèa
Notw"thstarKling that these may also benefft yyne ￿n￿1n0n￿nCer palients residing oulside the ch8ritys area.
The TTusle8s havè paid due regard lo gu￿1a￿￿ tswed by the Charity Commtssion in deciding what acttvities the
charity should undertakè. The Tnjstees consKler the objeetives and acalvit￿ of the are of a b8n9fft.
Athvitie$ of th• Charlty
Lingen Davies exists to enhance cancer serVi￿S arml improve INes in Shropshire. Tetrord & Wrekin. and Mid Wales.
We do this through Iwo m8in streams ofwork.
Grant making
The charity rais8s fijnds for projects which a ￿&sItiVe drfferen¢x lo thè lives of people INing wtth can￿r in
Shropshire. Teword & Wrekin and Mtd Wales. Donation5 are made lo local hospitals. tharities. and other bod%es to
assist with purchasing specialist equipment. imk¥owr¥J treatment spa(£s aThJ supporting communty-based projects
to improve the health and wdlbeing of peop￿ Imng ￿th and beyond 1￿c￿r.
Grant applications are assessed by the Grants Commiitee. a su1￿￿)Mmrttee of the Tnjstee Board, and then
confirmed by the tnjstees Whe￿ the value of the grant requires this. Grants are assessed against the aims and
objects oflhe cknarity, ensuring that the proFwl shows a dear benefit to ca￿r pathents and servi￿.
Close ￿MTnun1(Xts.0n is maintained wtth grant ￿CipIents to ensure that Ihe grant maknng priKess is as su(tessful
as possible and achieves maximum pU￿1C benefil.

LINGEN DAVIES CANCER FUND CIO,
CONTENTS
TTUStee5' report
ststement of Trustees. reskX)nsibi1￿eS
Independent auditorfs report
10-12
Slatement of fmanrAal aGtrti&s
13
Balance sheet
14
St8t8ment of cash fk)ws
15
Noles to the financia staler￿ts
16-28

LINGEN DAVIES CANCER FUND CIO
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Ser¥l¢e Delivery
Our LiveLife project has really got off the ground year. as Covi(P19 Testriclions hav8 eased and publ￿ events
have been running as rK)rrn818gain. We have been running public h￿th awafeness camp8ign5, linking in wrth
nath)nal and regi(Fnal scrèening campavJns arKI aXF4orirwJ C$￿0￿5 ts Gommtssioning our (Y•vn mndinical support
sérvices for people wtth cancer.
We are worknng with local consultarw CamFthII Charfes Partnèrship lo evaluate the cxjrrent Provision of social and
emoEw)nal support serVI￿S available to people affeckny by txrw in our re9￿. a ￿eW to looknng at W8yS to fill
gaps in provisi¢)n, whafe these bewme app8renL
Wg are also ex131ed to be w<￿￿￿g in partnership NHS Shropshire. Telford and Wrthn to ddiver the Cfft20+
projecL This project is designed to inC￿aSe the uptake of (ancer SCTeening rn Communi￿e$ who are less likely to
engage sn the screening progrdmmes", partiujlarfy fcoissiNJ on people tsS1ing into the 20% mosl deprived
communities in the UK. We wll be delNering this pro1￿t in Telford & w￿kIn arKI h8ve ￿￿nIty app(MrFted 3 Cancer
Champion Cwrdinalor. who ￿11 ￿ joining the team in Juty 2022 to lead on this woiect.
We are continuing dis(aJs&ons Powys Tèaching Heatth Board, wth a vsew to launthing a project supportirrfJ
peoplè living with cancer in Powys. using rn￿eY left to Ihe chartty by a very geneTWS legator. We are hoping to
launch this in 2022.
This ￿ qUiC￿Y becoming a major stream ol for us. vth the seNice beiro exlretnety busy this y8ar. We aTe now
slruggling to fvlfil demand and make the rrKJSt of the opw)rtuntb"ès available to us. so we are looking to expand this
team in 2022.
Fundraising Actlvltles
Following a very ¢h8118nging 2020121 due to the impact of Covi&19. we are very pleased to report that we have had
a iewrd-breaksng year for fijndraising, wTih a total income of £1.077.07212021= £718.8871. This is the first time the
charity has broken the £1m mark 8nd is sc¥mething w8 working hard kn. for the last fve years.
We are v8ry proud of this, and it is lestament to the hard work of our staff team and wonderful vduntèers and
supporters, who have rallied round lo &nsJJre our maF)r appeal, to fund a rthv CT Scanner and extension to the
clinic rooms. was com#eted before Ihe rewsed dead11r￿ of 31 March 2022.
The challenges presented by the pandemic gave Ihe opportunty to rewew and reftect on wr fundraising
PTacti¢ss and sped up the process of diver5ty.ng ujr fijndraising adivibes. Our major events programme 15 now
back in full swing and b￿3ger than ever. and we have put muth more time into income streams such as CDrporate
engagement and buildiThJ relationships vthh trusts arHJ fouThJations.
We ate acutely aware ot hjrther Challer￿e5 in the fijlure, Ir￿udIng the oryoing impacls of BreKit. the war In Ukraine,
the Covid-19 pandemic anil the global eo)nofflic uftcertainty this (xeates. We need to make sure that our income is
sustainable in the firture. There are number of large donatmxts vrithin this overall total. and we are not naive about
the potential difficulties in ￿[AiCating this ts fuku￿ yea￿.

LINGEN DAVIES CANCER FUND CIO
TRUSTEES, REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Fundralslng Standards 1rrf0m￿0n CA162A
The charity receivès the maj¢ty of funds from the putlK.
la) The tharty undertake5 fvnd-r8i5ing thcwh Jjr inlemal res￿l￿S and staff team. We do not o)mmission a
professional fvnd-raisarlcommerual parb(xpator for these:
Ibl The charity is ￿gIStered the FuThJraising Regulalor and atxdes by good practices 5tsndards set out by the
regulator. The charity's internal Guide to Fundraising relects these and gNes inforrnation to staff and volunt68rs
about how lo fvnd¥8iso18gally. ethically and wrthin gr￿ practice staThlartls".
cl The charity monttors fund4aisbng thibes via the Twstee t(*rd'
(dl The ch8Tty received no cc*nF4aints aboLrt a(knit￿ for the purpose of fundraising during thi5 year,
lel The ch8tity has adopted winThptes of GDPR logi￿ation a150 has Safegua￿ing F*Jliues to protecl the data ol
vulnerable peoplè and other members ofthe wbiic from..
lil UnreasonatA8 intrus*)n on a pe￿On5' Ixivacy"
lill Unreasonable ￿￿￿stent approa(*es for the purkw of s(Ai(iliro or othemse prrywring money or other
propety of the charily,
(iiil Plaung undue pressure on a to give money (x other Fwrty.
Achlovements and porforn￿nce
Like many tharits"es, we have experierwl a tange of challenges presented by the Covid-19 pandemic. However, we
made some bold decisions during the pandemic. afKt maintained a fijll complemènt of staff, who spent their lirne
exploring new avenues of fundraising, maintaining ￿ntact wtth (xjr volunteers. and planniNJ for batter bmes ahead.
As a resu￿ of thÈs. our fundraigng has hrt the ground running as we come of the imn)ediate irvpad of the
p8nd8mic. We are extremely proud to have had a recor&breaknng year for income gèneration in 2021122, raising
over £1 million for the first time in thè charity's hist￿. This a tèstament to the hard work of OUT stsff tèam and to
the commitment and generosity of our supp)rters througlKMJt the community. While we are very pleased with this
SLWSS, we a￿ mindfvl of current lo(al and global challenges. and we must now V•vrk to m8ko this level of income
sustainable,. we ¢annot take fi foT 9rant8d.
We are plèased that the extension to the din￿ rooms in the Lingen Da￿aS Centre has been u)mpl8ted. and these
rooms are now in use. These rooms increase capauty for appoinbnents. give Sp￿ for telemedI￿ne ttjnsultab'ons
and therefore enable the clini￿1 team to resw)rKI lo changes In patient number5 and devdopments in treatment
options lo ènsure the best FX)SSttAe outc(￿ for patients. Thi5 prgect aso enabl￿ u5 to convert 8nothgr room in
the Lingen Davies Ceftt￿ into a small fundraisirKJ offi￿. wing us greater presence in the space and providing
additional working spac8 for the staff team.
The CT Scannei, also beiTrJ fvnded from our Last appeal. is on sile at thè knNJen Davies Centre and will be fully
operational by laté July 2022. This wll improve thè acojracy of treatment ￿8￿ning. 8naNing staff to better protect
patients from the harmfijl èffects of radiotherapy on norrnal b"SSLFe.
Our LweLrfe project is growng. for the first time in Ihe charity's history we have been asked to act as a delivery
partner for an NHS project. The Core20+ project is fvnded by the NHS aryj we are woMng tn partnership with NHS
Shropshire. Telford & Wrekin. as well as I￿al tharity Qube. to deltver this exciting pr(4ect. This is th8 result of some
long-temi, strategic work dÈv81(¥)Trng our exiemal relationships and uedibilty in the local B￿r. and we hope this
wrfl be the fir* of many agreements of this nature.
We are exrit9d to be expanding our woE1( bèyond our traditional fundraising fu major appeals, but still have
fundraising at the heart of what we do. We ar8 weil aware of the pressures faung our health services and on
peoples, finances and wl1 rnaintain dose links wtth I(￿1 NHS and local aulhcty bodies to ensuTr our plans
complernent wider strat8gies and contribLrte to s better Èxperience for peO￿e living ￿th cancer tn our region.

LINGEN DAVIES CANCER FUND CIO
TRUSTEES. REPORT {CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Our CT Scanner and Clinic RoornsApp8al- £812.830
We were very proud to complete our apFWt for mapr proje(Js this year the extension to the dinic rooms in the
Lingan Davies Cent￿. and a new CT ScaM8r for the rddiothèrapy department This total indudès the purchase of
three Ixxjches for use in the dinic rcoms. The I￿PIe110n of this appeal was delayed by 12 months due to the
impaci ol the Covid-19 pandemic, bLrt we are pleased to see these projécts comp￿￿ and ttr￿ ￿dIti.0nal Services
now available for the people of our ￿KIn.
Kick Canc8r- £YO.fKKI
Continuing ujr felationship with Shrewsbury T<y*n in the Cryntllunrty. W Canw is an ongoing project thal helps
people lo take part in physiral adivity to improve their mental arKI physi(21 wellbeing as they experience cancer.
Due to the iFnpact of Covid-19 and the wjlnerabilty of participants, Cancer has been delNered largely onl￿nE
this year.
ican Proiecl Pilot- £30.060
This fvnding has been given to Liles￿e Frtness to ddiver a pibt prr4ramme for the ican scheme to u)ntribute to
the positive h8alth of Cancer patienls. We have worked vthh Lifewe Fthess PTeviousty on the Gel Arttvè. Feel
Good scherne and so have g(XKI conf¥Jence in the qualty of thwr worl and their abilty lo run this pilot to an
excdlent starKJ8rd.
Pilot ijelivery indudes czn(w patients attending ten ￿annert and ktslly led. group sessions of t8ilored actiwty
lexercisel and inforniationleducation. wth behawour support. Eath session wll indude a tsilored edU￿tion session
thin a group seth'ng around set Ihemes and acttwb.es which have been identified through patient feedbackl
concems raised durirvJ the Get Actwe. Feel Good pr(wJrnmme. The effi(iency of the pik>t p]r)gramme wll be
thoroughly r￿arChed and gvaluated in paTtrbership wtth UnNerstty Centre Shrewsbury with a viff￿ to intagrating the
programme wthin the emergirrfJ CarH*r pathway'Prehabtlitaly)n' proce&8es.
This projèct was launched in Summer 2020 but Ihen pui on hdd due to Covml restricbons w¢thin the University and
feedback from p*ients that they w8re c￿￿enVY un(XYrrfots￿e meeting in groups. It r￿Stsrted in lale 2021 and the
pilot completed in M8Tch 2Q22. The proieci has devek)twI SKJn[￿4nty and we have recenlly agreed lo ftjnd 8 rd
out of this project for 2-3 y•afS.
Complementary Therw&8- Oncology Wards £31300
This project iq delivered by Sevem HospKe. and is focused on in-pabents staying on cancer wards at the
Shrawst*ury and Telforf Hospitals. FundirwJ has been agreed tor three ￿a￿s. Complementary therapies can hdp
patients wth pain relief. mental health and wellbeing during their treatmenl. which can stressful and drfficult
time for them. Patients Lxn benefft hLody from re￿IvIng complementary therapies duriro their treatment, but
unfortunately the of this PToie¢t was on hdd for some lime in 2020121 due lo the parKlemic.
How8ver. the project r￿starts￿ in Septernber 2021 after 17 months on and the team werè ￿lcOMed back by
the Palliative Care team at ix)th RSH and PRH open am)s. After a few weeks of us ￿n9 back on thè Acute
wards some staff cxynm8nt8d ￿ the wsitive affect their presence had on all the patients, not just the ones who
were ha￿ng hands-on-therapies. As Msiting was still reslrided at the end ol last year the tim8 the team spent wlth
patients and the hands-on-thefapies had more a tK>sthe and soothing affecl than beftjre.
We have not paid out any more in Ihis finanual year lo Ihi5 wcyecl, as the sèrvice was fvrmled with the remainlng
funds from 2019120, that wer9 urKtsed due to Ihe kN*dcty*n. We be pawng oui Year 2 of Ihis ￿ndIng in 2022123
and Year 3 in 2023124.

LINGEN DAVIES CANCER FUND CIO
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
RadarKeys- £633
We have be8n working in pathership North Shropshire PrFmwy Caro Netsw)rk to rAovide radar keys to people
INing with cancer. A radar key giv8s a￿sS lo putAic dIsa￿ed loilÈts. and these arè often requir￿ by people who's
cancer. or ￿e effeds of their treatrnent. means th* they need to access a toilet quickly, or requi18 space and
facilities to deal with thin95 sud) as stomas. when Ihey are away from homa. Patients arp offered the keys via their
cancer care coordinator in their GP practice. as part of their usual appointrnents. WE have already had some very
positive feedback on the project. from pÈorAe de￿I￿ng irwsed feelings of confidence and freedom at b&ing able
lo go oul knowÈng they will be able to accw a tollet il ttw need one. We aro in contact with all other PCN'S in the
region and intend to rc4e this project out across the area in the coming year.
As wéll as providing funds for extemal projects. we have expanded wr health promotion w)rk vrith th8 LiveLife
Projecl. We have attended pU￿1C events, wrjrkplaces and h¢gh streets gmng infonnation about the earfy Signs and
symptorns of (ancer, and encouragiTrJ peO￿e to seek help rf Ihey are ￿t)rrIed atK)ut chan9es In their body. We have
gNèn ¢yJt many hurKlreds of free sunscreen sachets, gNen lalks to uNnmunty groups and have rec8nUy opened a
consultatN)n h)okirYJ at gaps in social arKJ emlional SUWM)rt that we may be able to fill in the future. We are also
working with Powys Teaching He8tth B03td to lry and develop a communrty-based suptx)rt project for people living
with cancer in Mid wa￿S. There are enormous opwthnthes in this arèa of WC￿ and we are very eX(￿tad lor its
future.
Thanks
Th8 Trustees wish to exwess th&r thanks lo th8 peoFle of Shropshire, reIf￿d & Wrekin. and Mid Wales. vthose
supp)rt forthe charity has ￿en exceptiOr￿7 once again. We are living in very chaI￿ngIng tim8s, and we cYJntiTrue to
be amazed by th& wllingnwss of our supporters to give Iheir time. money and gocmlwill to support us, and people
affected by cancer in our region.
We would also like to thank the stsff team and ttJThJrabJlate them on ￿ &Xcepti￿al year of fundraising snd
development in the charity.
We also thank our patron, Lady Jane Hebef-Pwcy. fty her SUPFQrt arml ge￿ity.
None of the charity's work *vJkl be with(xrt the commitment of Ihe staff and volunteers, and the truste88
are very gratèful for thEs.
Str*eglc Developm•nts
Fdlwng a development phase in 2021 aTrJ earfy 2022. our new Strategic Plan will ￿ published in Summer 2022.
This will be 8¢companied by intemal okwational plans and KPI'S giving the staff team and trustees a dear vision for
the fLlture of the charity.
Our strategic themès remain untharvJed, and we o)ntinue to fr￿J$ our resour￿ on:
ImprovÉng cancer prevention and earfy diagnosis rates in (Kjr (a)Mr￿n￿
Excellent treaknent and services lo(%ny
Sutwrting peoKAe to live well. with and beyorxl r2ncer
We are making plans for fUr￿Ing arml delivering 1Th4ects that Uy)Irit￿rte to all of these strategic ttw)7es.
Flnancial r•Yiew
The attached Statem8nt of FinarKial Ac*vrbes kn the p￿V￿J from 1 April 2021 to 31 March 2022 refieGts the
incoming rasources. resoufces expended and the overall movement in tsJnd5 for thg year.
Our community fvndraising has ¢yyth"nued lo impacted by the Covid-19 p8nd8mic, but due to the diversifi¢ation of
our activities. other areas of fundraising have 9￿allY improved and th￿fOre we have had a very strong year.
We would like to thank the trusls who have suppyted u5 Ihis year. The Lady Fwestèr Trust. The Wenlock
Fo￿$ter Charitable Tnjst, The Westcroft Trust. The Lord Levethvlme Cha¥itatde Trust. The Wingheld Trust and the
Wynn Foundatson.
G hay6 dlW wmo Fnwous WPWt from k￿￿1 businesses aTrJ Wle th1(￿9hout our community. In
particular, we thanks Tdford Plaza Ltd. who have m* a Signif￿nt donati¢)n to fund the purchase of the Lingen
Dawes van, which wll be in use by mi&2022.

LINGEN DAVIES CANCER FUND CIO
TRUSTEES, REPORT (CONTINUED)
FOR THE YEAR ENDED 31 AIARCH 2022
Reserves
Wthin Trstricted fijnds as at 31 March 2022 is £52.449 whith repre6wts ex(*ss fijnds: this will be allocated to pay
for a scalp cooEing machine currenty in discJJssions wtth Sh￿WStroJry and Telfwl Hos￿al CarKer SeThices at the
Lingen Davies Centre. and thè remain(ter to Ihg ican woiect
The Trustees aim to keep t200,0(M) (2021". £2W.0001 in designa￿ reserves. to cover running costs In the event of
a 8eriou5 (2sh flow problem or other mai)r unforesegn expense5.
This policy has provided grnat reassurance during pand￿nIC all0v￿￿ us lo make the dec4&0n to continue
operating a lull staff team. As our income has been stronger Ihan expect￿ during thi5 peri￿ wr designated
reserves havtr not been utilised durirwJ thkg year.
The Trustees liaise with Sh￿V￿b￿ry and Telford HOS￿￿1 NHS Trust aThJ other organisations that prwde t>ncer
serwces locally to tdentify proiails on lo spend their fvnds.
The Truste8$ are of opiiion that tho ras￿rCeS they relain and anlic4pate receNitwJ in the fi￿re will them
to meet effectively Ihe current and fijture aims for Ihe rdief of oncer pabents in Shropshire. Telft)rd and Wrekin and
Mid Wa￿s.
The unresth¢ted free reserves of th9 ¢h8nty as at 31 M8r¢* 2022 were £￿Il.6T[ {2021: £549,158}. ThSs indudes
legacy donation of £357.643 that we intend to use primarily to supwri projects in Powys. as this 15 whère the
legalor lived. However, this was not a condition frr)m Ihe donor and the funds maybe spent 8lsewhere if a suitab
project is not èstablished in the ¢x)ming 12 months.
The capital commttm8nts ￿11 ￿ met by and fiJbJre furmjraksing (as per Th)te 221 and are therefor8 exduded
from th8 free reserves calwlation.
Invèstments
Thè Trustees are aulhorised to invest the assèts cl the in 7*thatever way they betkve to Le in th& besl
interests of the charity and ts obiectsve&
In light of the current èrxjnomic sittjabon. the Trustees have (xx)sKlered the ryK)st appropriate poliry for investing
funds and have agreed that retaining furKls in cash investrwts best meet their r8quirements lo generate income
whilst maintaining capital for the long term.
Risk management
The TnJstees have èxamined the may)r 5tral8gic. bJsin8ss arKI operat￿* risks whth the charity f8ces. The Chief
Executive Officer reports regularfy to trustees on matters of risk manage[r￿L The Audit and Risk Committee meets
regul8rty to review risks and bad( k) all Irustees to re[￿71[￿nd the steps that sh{M￿d be taken to fflinimkse
these risks, wherever possible.
The Trustees have implemented a Scheme of ddegatK)n. responsibilty to Ihe Chief Ex8(xJtive Officer for
operattonal risks. The Chief Executive Offiw aÈiends Audit and fvsk Commiltee meeting5 and e￿lateS serious
risks lo the Chair ofTrustees as appropriate.

LINGEN DAVIES CANCER FUND CIO
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Plans forfuture pe￿￿1$
We are working wth partners in Shrewsbury and Telford H¢wtWs TrusL NHS Shropshire, Telford and Wrekin, and
P￿S Te8thing Health Board. to devdop rtr8w proieds for the (￿MIng year. Thi5 wll be a combination of our
traditional fvndraising and giving of grants Eo enhance Tr￿1 oan(w s8Mces. and also wothiThJ in partnership with
other t*Jdie5 to deliver projeds oursdve
We are ox(ited to see the Lingen Davies van ffi the njad, ￿a￿lTrg us to get out tnlo our (x>mmunitiÈs mor8 easAy
and with a more prof8ssional appeararKe. We have agrewj to raise ￿ndS to suppcwt ican fw a fvrther two years.
following the successfvl pilot of Ihis proiÈcL ican is being developed and evaluat￿1 kn partnèrship University
Centre Shrewsbury. and we are very pleased to see this proiect devejoyng.
We are making plans for anolher excellent year of lurmknising èvents. aThJ k￿ng to grow our legacy fundraistng,
rKI inuease applications to trusts arKI foundati(x)s.
Our Chair of Trustees, Mandy Thom MBE DL. is st8ppirwJ down al Ihe end of her very suixwfvl t8mi of officè, in
December 2022 and ￿ are in the process of rewrfing a Chair to cwtinue Mandls excdlent I￿rk in leading
the boafd since 2016.
structure. governan￿ and management
The Lingen Davies Cancer Fund, Fundraising Offi¢x, Hamar Certre, Royal Shrewsbury Hospital. Mytton 08k Road,
Shrewsbury. SY3 8XQ is registered wth the Charity CommissK)nets. num￿{ 1160922. as a charitable incorporaled
organisation and the Charity was entered on Cha￿ty Commission Register on 16 March 2015.
The Charity currenlly has 13 twstees. The m8￿muM nunknr of trustees 15 15 and there must be a minimum of 5.
Truslees are appointed for a tem) of 5 years and new trustees are appointed with regards to skills, kno￿edge and
experien￿ needed for the effeclive administration of Ihe chanty. New Irustees go through an iFxluction procw to
ensure they are fvlty InfOr¥ll￿ aboul the charity and rfs aims an(1 i*)jedives.
The Board ofTrustees meets quarterfy txrt Ilwe are abo varwjus ccrfnmittees as frA10￿..
Finance
FurKJraising Support
Audrt and Risk
Grants and Projects
HR
The committees rneet in between tnjstee mee11r￿s. a5 requirwl. th8 Chair of eath committ* reports back lo
truslee meetings and makes recommermjations to the Board.
The Charity works dosely with Shrew5bury Telforrl Hospilal Tnjst and their Director of Corporate Govemance
regularty rew)rts on hospital tnjst Matte￿ to the Board. In addibon. staff appointed prior to 1st April 2020 are joinuy
employed by 1he Charity and Tnjst. The pay and r9mun8rati()n for key management personnel are guideil by NHS
pay scales.
Since 1st April 2020, new staff joining the Charity have been empknyed directy by LiThJen Davies Cancer Fund and
are not subject to NHS temis and ￿d*bOnS. However. we are (x)mmi1￿ to treabng our staff well. providing good
employee beneffts and ensuring a posibve workiThJ env1rcffl￿￿nt for all. An exterrtal HR consultant is engaged to
support the managemenl team in ensuri￿ apwwate HR pdicEs and pro￿ureS are in pla￿ and to h81p manage
any HR issues as they arise.
The day to day responsibility for njnning the charity is d￿egated to the Chièf Exeujtive Officer, Naomi AU(in. Naomi
retumed from Fnatemrty leave in earty May 2021, havTrng been covered by intèrim Stuart Reynolds in her absence.
Naomi is supported in the managetT*llt team by Operations Manager Louise Dawson. and H88d of Fundratsing
He18n Knight. Relevanl tasks are delegateil to the managemertt team and other members of staff.
The cha￿￿S Banker5 and Audrttys are detailed on the Legal 8fbd Administrative page at the t¥eginnin9 of the
Financial Statements.

LINGEN DAVIES CANCER FUND CIO
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Roference and Administrati￿ D•talls
The Trusl88s, who serveil duriThJ the year WEre:
AJ Thom MBE DL {chaiM￿nI
MrA Killey (Vice Chairman)
Mrs C H Thomas ([reasU￿r}
Dr N N Srihari
Dr G Eatough
Mr D Jackson
Mrs A Kenny
Mrs F K HLttcheson
Mr T Cooper
Mrc Leak8
Mrs J L B88v8r
Mrs VA Edwarrls
DrJ RJohnson MBE
Patron
The HonOura￿e Lady Heber*e
New trustees are elected by the existFng Board. The Chair of Trustees wrfl (XTrTTre to the end of her very successfvl
term ol office at the end of 2022. and ￿an$ are in ￿aCe to rec¥urt a rew Chair to ￿￿ce hèr and continue her
excellent leadership of the board.
The Trustees, rep)rt was approved by the Board ofTnJstees.
AJ Thom MBE DL IChairm8nl
Chaim)an

LINGEN DAVIES CANCER FUND CIO
STATEMENT OF TRUSTEES. RESPONSIBIUTIES
FOR THE YEAR ENDED 31 MARCH 2022
The Trustees are responsible p￿parIng the Trustees, ReF¥Xt finarKaal statements in ￿Cordsnee With
applicable law ar￿ United Ktrngdom Ac(x)unting StarK13rds {United Kingdom Generally Accepted A¢xx)unting
Prdcticel.
The law applicat￿e lo charities in England and Wales wuires the Trustees lo prepare firsancial statements for each
financial year which give a twe and fair wew of the slate of affairs of Ihe charity and of the incoming ￿sourceS and
apFlication of ￿sOurceS of the tharity for Ihat year.
In preparing th8se fjn8ntxal Staternen￿ the Tnjstees are rw4uir•J lo..
- select suitable accounting pdiaes and then ap￿Y t￿ (xjnyslenty.
- observe the methc*Ys an(1 pnnoes in the cha￿tieS SORP:
- mak8 judgements and estimates that ar& rèasonatAe
- state whether appliCa￿e accounting starthrds have been followed. subject to any maten.al departures disdosod
and explained in the finarrial statements- and
- prepare the finanaal statements on the gjing concem b￿9 unths it is inappropriate lo presume that the (*arity
will <X)ntin￿e in operat￿.
The Trustees are responSi￿e fry keeping suffiaent aco)unting records that disdose wth reasonable acwracy at
any time the financial pOSttK￿ of the chartty and enatAe them to ensure that the finawal statements comply with the
Charities Act 2011, the Charity IAccount5 and Reports) Regulalions 2008 and the prowsions of the trust deed. They
are also responsible for safeguarding the assets of the charity aThJ for laksThJ reasonable steps for the
pieventM)n and detecbon of fraud and other irwularilies.

LINGEN DAVIES CANCER FUND CIO
INDEPENDENT AUDITOR'S REPORT
TO THE TRUSTEES OF UNGEN DAVIES CANCER FUND CIO
Opinlon
We have audited the finanaal statements of Lingen Dawes ca￿er Fund CIO (the 'thaiitll for the year ended 31
March 2022 which comprise the statement of finanTral a¢tivtbes. the b8lanr£ sheeL the ststement of cash flows and
Th)les lo Ihe financial statements, induding s¥Jnificant ac(wntir¥J Oiues. The finanual ￿porting framework that
has been appli8d in Iheir p￿Paration is appli￿ble law and United IfjFyJom Accounting Standards, including
Financial Repo￿.ng Stsndard 102 The Finan￿al Reporting Standard applicable in the UK and Republic of Irgland
(uni￿ Kingdom Generally A￿epted Accounting Pr¥b"cel.
In our opinion, the finanual statements:
give 8 true and fair view of the state of Ihe thariVs aTrdirs as at 31 Marth 2022 and of ils inryxning resources
and application of resour￿. for the then ended:
have b88n prowly prepare(l in actr)rdan￿ wilh Uniw Kingdcffj Gerwalty Actspted Accounting Practice.,
and
hav8 been prepargj ￿ acuxOance with the Th]uirements of the ChaiitiesA¢t 2011.
8asls for opinion
We conducteil our audit in accordance Intemats'onal Standards (x) Aud￿ng (UK) IISAS IUKII and appliGgbla
law. Our responsibilities those staThJards are fvFther described in Auditorfs respyjsiknlth.es for the audit of
the financial statements section of our ￿pOrt. We are irKlependent of the chartty in accordance with the ethical
requirements that are relevant to our audtt of the financ4al st*ements in the UK. induding the FRC'S Ethical
Standard, and we have lulfilted our other ethiGal responsibilFtses in aCt(*dan￿ these requifements. We believe
that the audit e￿ene8 wè have obtained is suffi(ient and appropnate to prtivide a basis our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have widuded that the Trust*s' u$8 of tho wrBJ ¢￿1￿M basis of
aw)untiro in the preparation of Ihe financial slatements is appropriate.
Based on the %bY)rk wè have pthTrn￿. have Ev)t ¥Jentified any matsiia urKertainlies relattrwJ to events or
conditions that, individualty ￿ cdtecbvety. may ￿$1 significant doubt ￿ the chantys aknlity to ￿)ntinu8 8s a going
for a period of at least twelve months from vthen the financsal stalemenls are atrthorised for issue.
Our responsibilities and the rèSw)nsibdii￿ of the Tnjstees wilh respect to wng concem are described in the
relevant sections of this reporL
Other infomiation
The other infomiation comprises the Informa￿ induded in the annual rewmt other than the finan¢ial statements
and our audf(orfs ￿￿￿)rt th¢r6on. The Tnjstees are responsNI e for the other inforrllation contained wiihin the annual
reporL Our opiTrion on the finanaal Staten￿tS not (x)veT the olher infomation and we do r)ot èxpress any form
of aSs￿rar￿e conclusion th8r80n. Our resF¥)nssbilty is lo r8ad Ihe other inforn)ation and. in doing so. consider
whelher the other information is materially inconsistent wth thè finanual statements or our knO￿edge obtained
the course of the audit. or othe￿ise appeats tr) ￿ materidly misstated. 11 we identify suth matefi81 intx)nsistenci&s
or apparent matèrial misstatements, we a￿ required to detem)ine whether this gives rise to a material misstslefflenl
in the finanryal statements themsefves. If. based on the work we have perform&J, we ¢ondude that there 15 a
material misststemenl of this other infom)ation. we are required to re￿ that fa
We have nothing to report in this regarf.
Matt•rs ¢)n which we are requir￿ lo rnport by excepti
We have nothing lo re[￿ in r8spect of the fdlo*irwJ matters in relalion to whid) tho Charitses {Accounts and
Report51 Regulations 2QM18 require us to retM*t to you if, in our opinion".
the infom)ation given in ts finandal statements is Ir¥￿s1$t￿nI in any material respect with the Trustees.
reporL" or
sufficient 8(xx)unttng records have not been kopt: or
the financial slatements are not in agreementwth the accoLtntiThJ rewrds; or
we have not re¢eiv8d all the informatK)n eW8nations we ￿)Ul￿ for our audiL
10-

LINGEN DAVIES CANCER FUND CIO
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE TRUSTEES OF LINGEN DAVIES CANCER FUND CIO
Responsib51itles of Thistees
As explained more fully in the staieff*nt of Trustees. ￿$1￿sIbIl￿es. ￿ Trustees are responsible for the
preparation of the financial statements and for being $8ti5fied th81 they gTve a true and fair vw. and for such
intemal control 85 the Trustees deternine is necessary to enab￿ th8 pr8paratK)n of finaficial statements that are
free from material missialemenL whether due to fraud or error. In preparirrfj thè financial statements, the Trustees
are responsible for assessing the charrty's abil￿ to conlinue as a g(Mng 1x)n￿rn. disdosing, as applicable, matters
related to going concem and using the wing (xjncem basis of ￿KI￿ting unless the Trustees either intend to caas8
operabons. or havè no reatislic 8lternatsve but to do so.
Auditorfs r•sponslbllltlès for th¢ •udit ot the financial statements
We have been aP￿tr￿ted as auditor urKler seclion 145 of the Charibes Att 2011 and report in a￿aft￿ with the
Act and relevant regulati)ns made or having effect thereurmlef.
Our objectives are to obtain reaSona￿e asSlTrr￿ about ¥rt￿th￿ thè finanwl ststements as a whole are free from
material misstatement, Tr•thether duè to haud or error, and to issue an auditorfs repc￿t that indudes OUT opTrnion.
Reasonable assuran￿ is a high level of awjtsnce but is not a guarantee that an audit conduth in acctsrdaneè
with ISAS IUKI wll always detect a material misstatem8nt when it Misslat8m8nts can arise from fraud or
error and are conSide￿d material rf. individualfy or in the aggregate, they (￿JId reasonably be expect8d lo influence
the economi¢ de￿￿on$ of users tsken on the basis of these finanual slatements.
The extent to whith proc8dures are capat4e of detecliNJ trregularilies. fraLKI. i8 detailed beh)w.
we identified the faws and regul8b.ons appficatrAe to the Charity Ihrough discussions with th8 Trustees and
other Manage￿￿1, and from our kno￿edge and eX￿rien1> of the Charrty seclw,
we focusad on sp8cific18ws and regul81ion5 which we consider&J may have a direct material effec* on the
finanoal slalemenls or the operations of the charity. induding thè Charity Act 2011 and iaxation and data
protection.,
we ensured th8t th8 manayemeffl team have the appropriatè competence. capabiltbes aThJ
skills to identsfy or recognise noTr o)mFliance ￿th applicable laws and regulati(￿S., and
identifjeLI laws and regulations We￿ communi(2ted wÈthin audil tsam regulady and the team remained
alert to irsstances of non-compliance thff>ughotrt the aud
We assessed the susceptibility of the financi81 statements to material mi&8tatement, induding
obtaining an undeTstsrKling of hLAV fraud rn￿ht ctcur. by:
making enquiries of management as to where th8y l￿der￿j there was suscepts'bility to fraud, their
knowledge of actual. suspect8d. alleged fraLhd: and
considering the intemal contrds in place to mitigate risks of fraud and norHX)mpliance with laws and
regul8tions.
To address the risk of fraud through managÈnwt bias aThY oveTride of controls. we..
p8rformed analytic21 prcKedures to identify any unusud or un8xp*d relationships,.
testjoumal entries to identify unusual transaclions.,
assess whether judgements and assurnpknns made in detemiinirKJ the a¢xJunb"ng estimates sel cth we
indi￿live of y)tentHI bias- and
investigatèd the rati￿ale behind sFJniknt or unusual transadions.
11

LINGEN DAVIES CANCER FUND CIO
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE TRUSTEES OF LINGEN DAVIES CANCER FUND CIO
In resporw to the llsk of irregularibes and n(￿￿￿￿18n(￿ with la￿ aTrJ regulati(￿, W8 designed
proce(lur8s wthich induded, bLSt were not limited to:
agreeing finan(xal statamenl dk8dosures to underfwng suptx>rting tkxxJMenlatic￿',
reading the minutès of maatings oflhose charged governance: and
enquiring of management as to actual and potenliJ libgation and daim.
There arè inhérent limitatwms in ￿Jr audit prowlures ￿&s￿b￿j above. The more removed that laws and
regulations are from financial tr8nsacbons. thè lèss likdy it is thal we would become aware of non-
compliance. Auditing stsndards also limit the audit pro(xdu￿s required to Hlentify n0rpcomp1iar￿e wth 18ws
and regulations to erouiry of the trustees and other man899m￿t 3nd the inspection of Tegulatory an(1 legal
correspond8n¢*, if any.
A fvrthar description of our resp￿sIbIl[lieS 15 awdilalAe on the Financial Rep)rting c(￿7.S wgbsttè aL htlps'.11
www.fro.org.uklaudrtorsresponssbilities. This description forrns part of ¢MJT auditorfs repc*t.
Oth•r matters
This report is made scAely to the (x)mPa￿S members. as a txxty. in accordance wtth section 391 of the Companies
Act 2014. Our audit work has been undertaken so that W￿ mvJht stste lo the wmpany's membèrs those matters we
are requireil to state to them in an auditorfs report and for no other pur￿. To the fullest extent Permitted by law,
we do not 8ce6pt or 8ssum8 r8spofkgibilty to anyone other than the o)mpany and the company's m8mbeT5 85
body, for our audit work, for thkg report, or for the wnions we have formed.
Cagr¥¥yn Jones
Chartered Accountants
Statutory Auditor
Emstrey House
Shrewsbury Business Pa
Shrewsbury
SY2 6LG
I{ Lo
Caervtyn Jones is elwJit4e for appointrment as auditor of the charity by wrtue of its gligibdty for appointment as
8udilor of a company Ufthr sethon 1212 of the CompaniesAct 20(K.
12-

LINGEN DAVIES CANCER FUND CIO
STATEMENT OF FINANCIAL ACTMTIES
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2022
Totsl Unrestrleted R•strlcted
funds
fvnds
2021
2021
Total
funds
2022
funds
2022
2022
2021
In
tsme from:
Donations and lega(>ès
Gharitable activities
Other tradin9 activities
Investmènts
286.077
598.749
44.636
144,341
1.232
884.826 389,139
44,636
145.090
2.520
272.226
661,365
749
1,288
48,586
48.586
8,936
7.927
T<rtal incom8
288,114
788,958
1.077.072
397.1
321,821
718,887
Ex
iture o
Raising funds
28.OW2
216.940
245.022
23.860
148.763
172.623
Chartiable activÉbes
133.897
812.830
946.727
1￿.658
158,rro
355.428
Total exp•ndltUTe
161.979
1.029,no
1.191.749
220.518
307,533
528.051
Gross transfer5 bth*n
furKIs
Net incomèl(expenditurn) for
the yearl
Net movement In funts
(29.8451
29,845
126.135
1240.8121 1114.6771
146.703
44,133
I￿.836
Fund balarKes at 1 A[￿1 2021
783.¥24
337.W38 1.121,822
637,221
293,765
930,986
Fund ￿lanCeS at 31 March
2022
910,059
97,086
1.CK17.14S
783.924
337,898
1.121.822
The ststament of finanaal acli¥itss indudes all gains and k)sses re¢(yJnised in Ihe year.
l In￿Me and expendÉiure derive from c4Jnlinuing aclivibtss.
13-

LINGEN DAVIES CANCER FUND CIO
BALANCE SHEEr
ASAT31 MARCH 2022
2022
2021
Fixed ass•ts
Int8ngible assets
Tangible assets
13
14
1(X).382
108,382
3.666
Curr•nt assets
Stocks
Debtr)rs
Cash at bank and in h¥nd
15
16
638
235.638
1.520.814
2,219
39,458
881,581
1.757.0
1283,258
Credit¢rs: amounts falllng due within
one year
17
(858.327)
1165.1021
Net cul￿nt assets
898.763
1.118.156
Total assets less current Ilabllltles
1.007.145
1.121,822
Income funds
Reslricled funds
Uniestricted funds
Designated funds
Gèneral unrestricie(t funds
97.086
337.898
19
200.000
583.924
710.059
910.059
783,924
1.007.145
1.121,822
The finanaal ststements were approvÈd by the Trustee5 1)n..
Mr
A J Thom MBE DL (Chairman)
Trustee
14_

LINGEN DAVIES CANCER FUND CIO
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2022
2022
2021
Cash flows from opèrating activi1￿$
Cash generated from 0[￿tionS
746.833
29.279
Investing activities
Purchase ol intangible assets
Purchase of tangible fixed assets
Investment income ￿Ceived
{12.(￿)
198,120)
2.520
14,1511
8,936
Net cash Ius8d Inygenerated from
tnv•sting activities
(107.6C(J)
4.785
Net cash used in financing activltl•s
Net increase in cash and cash •qulv*nts
639.233
34.064
Cash and cash equivaents at beginnirvj of year
881.581
847.517
Cash and ¢a$h equi¥alents at end of year
1,520.814
881.581
15-

LINGEN DAVIES CANCER FUND CIO
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022
A¢eountlng policies
Charlty Infomiallon
Lingen Davies Can￿r Fund CIO is a (￿arrta￿e incorForatwJ ¢xganisat*)n. register&1 in England and Wales.
1.1 A¢¢ountlng conventloD
The financial stst8rnents have been prep8re(l in ac0)rd8￿ the charitys goveming document, the
Charities Act 2011 8nd "Accounting arwj ReportirKJ by Chaiibgs.. Stat8ment of Reo)mrnend8d Prackn
applicable to ch8ribe$ preparing their a(x£wnts in accordance with the Financial Reporting Stsndard
applicable in the UK and Republ￿ of I￿land IFRS 1021" las amended for ￿nting perityjs commencing
from 1 January 20191. The c*arity i8 8 Publi¢ Benefit Enbty as defi[￿d by FRS 102.
The accounts are prepared in stertiThJ. whith is furKkn)al ojrrency of the dwity. Monelary amounts .
these fin8n(xal statements a￿ rouNJ8¢J to the nearest £.
The 8rawnts have been prepar•d on the h1$kn￿l cost convention. The prin(ipo1 accoLsnting Fdicios adopted
are Sel out bek￿.
1.2 Golng concern
At the time of approving the financial statements, the Trustees have a reasonable expectstion thal the charity
h8s adequale resoLsrces to ￿)ntinue in Operation￿ existen¢x f(K the loreseeable future. Thus the Tnjstees
¢￿ts"nu& to alopt the going o)rwn bas￿ of ac(xyJnting in prep3rirtsJ Ihe finanoal ststelr￿nts.
1.3 Charftable lunds
Unrestr¥cted funds are availat4e for Ltse at the discrelK>n of the Tnjstees in furtherance of Iheir charitable
objectives unless the funds have been dgsKJnat8d for other PLtrposes.
Un￿Stn"cIed fuThJs are dona￿n$ and other r￿￿ed for the gewal thiects ofthe tharity.
Restricted funds are subj'ect to speufic {a)ndib.￿S by donors as to how they may be uwl. ￿ PUryK)ses arKI
uses of the re5tn"¢tod fvrKls are set Ixrt sn the nirtes to the Slaten￿ts.
1A In¢ome
Ir￿me 15 re￿nISed vthèn the chaEity is18gaty ènliuèd to it aft8r any perfomiance ¢))nditions have been me(
the amounts can be me8surwt reliably. and tt 15 probatA8 that incomè ￿11 bè r￿1ved.
Cash dcfflalions are recc¥Jnis&J on rec￿pl Other donakns are re￿niSed the chartty has bèen notffi8d
of the donation, unless perfOrn￿r￿ ￿lditiOnS r8quir8 defgrral of lh8 8m(x]nt. In(x)Ine tsx re(x)verable in
r8lab.on to donatity)s r￿1¥8(1 urKier GrfiAM1 or deeds of covenant is rec(yJnis&1 at the time of the donation.
Legaues a￿ re(wnised on re(*rpt or otherwse rf the tharity has been notified of an impending distribution,
the arnounl ss known. arvj receipt is exl￿ell. If the amount is not knovm, the legacy is treated as a
contingent asset
Assets given for use by the charsty are recrynis&J wtRn ￿￿T¥able.
Income from governMenl arxl other grants. vthether'capitaf grants or'revenue. grants, is recognised when the
charity ha5 entiuement lo the fvnds. any perf￿n8￿c* ¢y)rKlitÈons attathed lo the grant have been met. it Is
probable that the income wll be receNed and the arr￿U￿t be measured rdiabty.
Tumover is Measu￿ at the fair value of the consideralion receNed or receivable 8nd represents amounts
receivable for 9(￿S and services in the r￿na5 course of trojslr￿S3. net of disownts. VAT and other
sales related tsxes.
16-

LINGEN DAVIES CANCER FUND CIO
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Accountlng policse
Icontlnuedl
1.5 Expenditur#
Expenditure is recryJnised Ihere is a *al or construc*¥e oblwjation to transfèr aconomic benefft to a
third party, it IS Probable that a transfew of economK b8nÈfils wll be rwuired in sethemenL and the amount of
the oblKJation bè measured reliabty.
Expgnditure is dasSi￿d by aclM"ty. The costs of earh athity are made up of the totsl of direct cos15 and
shared ￿Sts. indudsng supwrt o)sts irwdved in LIndertak￿Y eath actNity. Direct costs attributable to a single
activity are allocated dir9Gty lo thal activtty. Shared costs whith contribute to more than one activty and
support costs vA)ich are not attributable to a single activty are apporliorhed between thostr activthes on a basis
eonsistent with the use of resources. Central staff (x)sts are allocated on the basis of time spent, and
depreciatson charges are albcated on the tM)rtsM of the a&%et's use.
Direct ChaTitable E￿ndItsJre
The objects of Ihg d)arity are lo rai$8 funds to F¥ovidg grants to SUPF4Yt thè of cancer h$8lth care
professionals lor the treatment of cancer patients in shropshi￿. Telford and Wrekin and Mid Wales, the
provision of services dire[* to cancer pab.ents raising awarèn￿ ol cancer prevention in the area. Any
èxpenditure spe¢ffi(2lly to achieve th￿ otyects is indijded in direct charrt8bl8 expenditure.
Governance eosts
Administrab"on expenses of the charity rel8t8 to the o)sts of runniThJ the charity. such as insurance.
accountancy fees and o)sts of slxtuiory com￿l8r￿￿. and wdude any Ixksts vA)ich canr￿t be spgcÈfically
attribul8d to anolher expenditure dassÈft(ztity).
1.6 Intangible fix￿ assets othèr than goodwill
Intangible assets acquired separately from a business are recognised 8t (x)sl and are subsequentty m¢8sured
al cost less aL￿M￿lat￿￿ amortisalion arKI a￿￿mlIaEed impgim)ènt losses.
Intsngible assets acquired orb busll)ess combinations are recognised separately from gcthfjll 81 the
acquisition dale where it is prOba￿e that lh& Èxpected fl￿jre e(x>nomic benefits that are attributable to the
asset will flow to the entity and the fair value of the asset (an be measured reliably," the intangible asset arises
from contracttjal ￿ olher leg￿ r￿hts. and the intangible 8&%8t is separalAe froffl the entity.
Amortisation is re(wnised so as to 7Kite off the cost or WdIuat￿ of assels tess th86r reskjual values over their
useful li￿$ on the fdk)wing bases".
Website
33.33% PA. on cost
1.7 Tanglbl• fixed assets
TangitAe fixed assets 8fE intbally measure(l at u)st arwj SLt6equenity measurgj at cost or valuation, r*t of
deprKiation and any ifflparmenl losses.
Depreciab"on is recognised so as to write off the CKtst or ValUatic￿ of assels le5$ thalr residual values over their
Useful lives on the follow7ng bases:
Equipment
Soknre
Motor vehides
20% p.a on cost
33.33% p.a on cost
25% p.a on c05t
The gain or loss arising on the d￿1 of an awt is determined #s the drfference between the sale proceeds
ar￿ the carrying value of the a&%et. and i8 recx)gnise(t in Ihe State￿￿Trt offinawal adiwties.
17-

LINGEN DAVIES CANCER FUND CIO
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Accounting policies
Icontlnuedl
1.8 Impairnwnt of flxed assets
At each repofbng end date, the charity reviews the carying am￿nts of its tangible and intangible assets to
deterrnine wheth8r there is any iTrJication that those assets havè suffered an impairment loss. W any such
indication exists, the Feeoverable amount of Ihe asset ts estimated in order to detemine the extent of the
impairment loss (rf any).
1.9 Stocks
Stod(s are ststsd al the lower of cost and eStirnat￿ selling pri(x lè&8 cosls lo com￿ete and sell. Cost
compTises direct materials and. vthere 8NAI(x￿e. direct labwr costs and tlx>se ovetheads that have been
Sncurred in bringing the stoc*s to their pr8s8nt location and (￿ndItion. Item5 hgld for disln"bution at no or
n¢Mninal consideration are measured al the lower of re[Aa￿￿t cost and cost
Ngt réalisable value is the estimated selliru prth lass all estimated c3)s13 of c(￿￿81%￿n and cosis to be
incurred In marketing. selling and distribution.
1.10 C•$h and equlvalents
Cash and cash equivalents indude ￿$h in hand. deposits held al with banks and olher short4erm IiquKI
invostsnents wtth original maluTitses of three ￿K￿thS or less.
1.11 Employee beneffts
The cost of 8ny unus8d tK)fiday entruement is Tecognised in Ihe per*JJ in whbth the emFAoyee'$ seryic8s ara
received.
Tamiination ￿nefftS are recogni8ed imrnediatety as an ex[￿Se when the tharity is demonstrably committed
to tem)in*e th8 ampk)ymant of an employee orlo pThid9 teminatK)n beneffts.
1.12 Retlr•m•nt ￿nefits
Payments to defin￿1 CDntrIbutK￿ relirement t￿efft schemes are d￿rged as an ewse as they fall due.
18-

LINGEN DAVIES CANCER FUND CIO
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Donations and legacies
un￿Stricted Re5tTiCted
Total Unrestricted Restricted
fijnds
funds
Total
2022
2021
2021
2021
DOnat￿nS and gifts
Legaues ￿CeiVable
Grants re¢eivaNe
117.394 400.
164.315
517.398
169.315
198.113
13,854
374,298
244.9
2.724
24.593
258,763
377.022
25.580
193.745
286.on
598.749 884,826
389,139
272.226
661,365
The amounts shovm alx)ve indude unpaid1gg￿$ Wh￿ due to the time and C￿mple￿ty taken for legacies to
crystallise, this income may not be re(%NwJ wthin 12 Wth"n debtors at the year end unpaid legaaes
amount tts £157,711 12021.. £370.685).
Grants re¢eivable for
core activities
CJRS Grant
ShTopshirè Councj
Other Grants
1.293
5.000
18,300
2.280
5,000
18.300
193.745
197.TT9
193.745
198.113
24,593
25,580
Charttable activilieg
R•strlcted
fvnds
2022
2021
LNeLrfe
44,636
Other tradlng aCtlvltl•s
Total
Restricted
funds
nds
funds
2022
2022
2022
2021
Fundraising events
erchandise
749
123,271
21.070
124,020
21,070
21,641
26,945
749
144.341
145.090
48.586
19-

LINGEN DAVIES CANCER FUND CIO
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Invostsnents
Total Unre5trithd Restricted
fvnd
Total
funds
2022
2022
2022
2021
2021
2021
Investrnent income
1232
2.520
7.927
8.936
Raising funds
Total Unre51ri¢Aed Restricted
ftjnds
funds
Total
fvnd$
funds
2022
2022
2021
2021
2021
Fundraisi
staging fundraising
events
Advertising
Other fundraising costs
Stsff cA)8ts
Depreciation and
impairmertt
8,174
395
37,935
7,144
9,534
149.134
46.109
4.769
13,359
15,220
11￿.965
4,769
13.359
15.410
119,928
10.880
167.301
18.167
18.
4.707
4,707
Fundraising and pU￿1¢￿ty
28.082
203.747
231.829
23.8fil
134,313
158.173
Tradin
Merchandise
13,193
13.193
14.450
14,450
28.082
216.940
245.022
23.860
148.763
172.623

LINGEN DAVIES CANCER FUND CIO
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Charitable activities
2022
2021
Grant funding of ￿.￿lieS {seÈ mte 8)
829,928
273.784
Share of suptK)rt rA>sts (see note 91
Share of govemance costs (see note 9}
114,1
2.609
79,546
946,727
355.428
Analysi¥ by fund
Unrestricted funds
Restricted funds
133,897
812,830
196,658
158,770
946.727
355.428
Grants payablè
2022
2021
Grants to insliiutKJns:
Clinical Nurse Sp8eialists
Clinic Rooms
CT Scanner
Bladdor Scanner
ican Programme
Hamar Center Extension
Complementary Therdpies
GetActive Fed Good
Radar Keys
Ki(* Cancer
78,677
372,455
440,375
7,059
27,060
59,795
11,100
80,093
3.465
633
10.000
10,OLN)
829.928
273.784
Grants payabl8 from unTestrthd funds to £17.rJ98 12021.. £115.014} and from r8strict8d funds
£812,83012021.. £158.Th01.
-21_

LINGEN DAVIES CANCER FUND CIO
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Support costs
Support Govwnanc•
2022Supwrt (x)sts Goveman
(x)sts
2021
96,010
5,4C
8,033
4.743
96.010
75.274
2.087
2.185
75,274
2,087
2.185
DèpreuatKJn
Overheads
Training
8,033
5.132
AUd￿t fees
Trustee indemnity
insLFrar
1.750
1.750
1.740
1.740
470
470
358
114.19)
116.799
79.546
81.644
Anatysed
CharitatAe activitss
114.190
116.799
79.546
81,e44
10 Not movement In fvnds
21)22
2021
Net movement in funds is stated after thargil￿1￿cK8dilI￿jI
Fees paydble to the (x)Mpan￿S aLMlitor for Ihe audit of the finaniial
statements
Deprecsation of owned ta[￿l￿e frxed assets
Amorbsation of inl8ngible 8ssets
1,750
1,404
4.000
1,740
6,794
11 Tntsteas
N¢)ne of the Trustees lor any pe￿OnS ￿￿ne(led wilh them) any remunaralion or benefits from the
charity during Ihe year.
During Ihe year Ihe tharity ￿1ved donalM)ns ftvm nir* trust￿ (2021". fcAJr). ￿0(rt conditions totalling
£3.756 {2021.' £1.8371.
12 Employo8s
The average monthly number OfeM￿ duriro the year Wds:
2022
Numb•r
2021
NuM￿r
AdminiStra￿n

LINGEN DAVIES CANCER FUND CIO
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
12 Employ8es
{Continu¢dl
Employment costs
2022
2021
Wages and salaries
ial security costs
Other pension costs
224,940
20,074
18.297
162,318
14,234
18,650
263.311
195.202
There were Th) ern￿OYeeS whose annual remuneratw)n was nKYe than £60.(￿.
13 Intanglble fixed assets
W8b85te
Cost
At 1 April 2021
Addthons- separately av4uirad
12.0
At 31 March 2022
12.0(KJ
Amortlsatlon and impairn*nt
At 1 April 2021
Amortisation char￿￿ for thè year
At 31 March 2022
Carying amount
At 31 March 2022
8.Otx)
At 31 Marth 2021

LINGEN DAVIES CANCER FUND CIO
NOTES TO THE FINANCIAL STATEMENTS {CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
14 Tanglble fixed assets
Total
At 1 April 2021
Additions
11.055
2.720
13.980
25,035
98,120
95.41KJ
At 31 March 2022
13.T75
13.980
95,400
123,155
Depreciation and impaimient
At 1 April 2021
Dep￿￿atiOn charged in the year
7.389
13.9
21,369
1.404
At 31 Marth 2022
8.793
13,980
22,773
Carrying amount
At 31 March 2022
4,982
95.41K)
l(Kl,382
At 31 March 2021
3.666
3.666
15 Stocks
2022
2021
Finished goods and g(MJds for resale
638
2.219
16 Debtors
2022
2021
Amounts falling due within one year.
Trade debtors
Prapayments arKI actyu8d income
52,975
182.663
2,000
397,458
235.638
399,458
17 Creditors: amounts tslling due within one year
2022
2021
Accruals and deferred income
858.327
165.102
-24-

e400
0>00
00
i (N ¢J
mo
otso

LINGEN DAVIES CANCER FUND CIO
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
19 D•signatsd funds
The inc4Jme funds of 1he charity the frAb)￿ de&gnaled fijnds vthich have been set aside out of
unre5thded lunds by the Iwstees for speafic pu￿)Se5.
Movement
In funds
Irthming Balan¢• at
1 Awil 2021 FE$oUr￿ 31 March
Èn funds
1 Awl 2020
2022
Running costs
2￿.000
200.C
200,000
Anatysls of n•t ass•ts bètw••n funds
Totsl Unreslricled Restricted
2022
2021
Total
2021
2022
2022
Fund balances at 31
March 2022 are
r6present8d by..
Intsngible fixed assets
Tangible assets
Current assetsllliabiltbesl
1￿.382
801.67T
100,382
898,763
3.666
780,258
3,666
1,118,156
97.086
337.898
910.059
97.086
1.007.145
783.924
337.898
1.121.822
21 Purpose of funds {mat•rlal funds onty)
Unrestricted funts
The unreStr￿cted reserves r9present a£￿￿vIa￿ furKts r￿1Ved which are free to be l￿ed wlhin the
obj'ectives ol thè tharity. These fur￿ are a¥aaatrAe for the fvtUTe funding negts and wothng (2pltal of the
ch8rity.
D•signated r#seTves
The running cost reserve is a fund set aside to rn￿1 the 12 ￿￿th Nnniryd costs of the d)arity. rf fundin9
sources ceased or reduce4d.
Restrlcttd re5erve5
2019-21 Appeal
A new ap￿81 was stsrted in 2019 to raise fvrther fvnds to assist SaTH new projects. We agreed to
fundraise approx £370,000 for an extension to the Lingen Dames dinic rooms and £450,000 for a new CT
Scanner for thè R8diotherapy d￿part￿enl These projects were delayed by 12 months because of Covid-19
but were Corn￿eted in March 2022. The balan￿ left in the Appeal will be albxated to buying chemolherapy
Ccd Caps in 2022123 . with the remain¥ng lunds g￿n9 to the ican proJecL
The charity is wothng wtth NHS ShropshI￿ Telfortl and to deliver the Core20+ proiecL designed lo
increase th8 Uptake of S(yeening in Telford afKI Wrekkn.

LINGEN DAVIES CANCER FUND CIO
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Capltal commiti))ents
In 8ddtbon to the grants already made in Note 8. 8t the end of ￿ year. Ihe Charity has commrtted to pay
grants from current fur￿5 and firture fijnd raising for the followng:
Unrestrictsd funth
Cool Cap
Kick Cancer
Holisb"c Therapies
ican Programme
£18.IXM)
£10,OC
£11,100
£502.750
23 Related party transactlons
R￿uneratIon of key rnan•gem￿ peTronn81
The remuneration of key m8nagèment persmnd is as folows.
2021
Aggwate Compe￿tion
116,¢X)9
97.354
During the year. one empknyee rereNed a diS(x)Un￿ b8ll tK*èL whi(a) was availab￿ to 811 ern￿OyeeS. total
sawng of£25.
Transaetlons with rolat￿ parties
During thè y6ar tnjstees purchased merchaThJise aThJ t**ets for events from tharity al full cost lotalling
£546 {2021.. £1.1951_
Abbeyfest was a pr(4ect in whith L￿gen Dawes worked in pathership with sh￿WSbury Abbey and Pop Up
Shrop Ltd. Pop Up Shrop Ltd is owned and fflanaged by Da￿en Tomkins, wFK> is the partner of the Lingen
Dawes CEO. ￿1 of Darren's time was o)mmitted on a volunlary basi8 to the project and all services and
purchases invoiwl to the tharity were given at cost price. No profft was made by Pop Up Shrop Ltd hi)m this
event.
Dyke Yaxley Ltd. in whith MTS F K Hutcheson VRS DirwAor. wiyAied the ¢*arrt￿S a(uxJnting software al an
annual cost of £34612021.. £365}, payrdl services at a cost of £30612021.. £4321 and also assist with the
preparation of the Finan(aal Statements on a wo txino b￿"* The balan(* owed at the year enrj w45 nil ft)r
2022 and 2021.
-27-

LINGEN DAVIES CANCER FUND CIO
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
24 Cash generated fTom operations
2022
2021
IDefi¢itVsurpu5 forthe year
1114.677)
190.836
Adjustments for..
Invesiment income recognis&Y in statement of fin8nci81
Amortisatson ar￿ inipairrnent of intsngible as5trts
Depw#ation and imp8imient of taThJitAe fixed assets
(2,5201
18,9361
1,404
6.794
Movements in working Ca￿1.
1,581
163,820
693,225
609
1241,9261
81.902
Dècreas8llincreasel d8bt<ws
Increase in ¢rÈdilors
Cash generated from operntions
746.833
29,279